1. Editor-in-Chief’s Commentary: Innovation in Publications

   • Stephen P. Spielberg

   Commentary 30 December 2013 Pages: 151 - 151

2. Cycle Time Metrics for Multisite Clinical Trials in the United States

   • Diana Abbott
   • Robert Califf
   • Swati Chakraborty

   Clinical Trials Open access 30 December 2013 Pages: 152 - 160

3. Quality by Design in Clinical Trials: A Collaborative Pilot With FDA

   • Kenneth Sprenger
   • David Nickerson
   • Briggs W. Morrison

   Clinical Trials 30 December 2013 Pages: 161 - 166

4. Evaluation of Blinded Independent Central Review of Tumor Progression in Oncology Clinical Trials: A Meta-analysis

   • Jenny J. Zhang
   • Huanyu Chen
   • Rajeshwari Sridhara

   Clinical Trials 30 December 2013 Pages: 167 - 174

5. Life Cycle Modeling and Simulation: Current Practice and Future Impact on Health Care Innovation and Delivery

   • Michael O’Kelly
   • Seth Berry
   • Andrew Garrett

   Clinical Trials 30 December 2013 Pages: 175 - 182

6. Expanding Consumer Medication Access: The Time Is Now

   • Sally A. Huston
   • Suzan Kucukarslan
   • Sujit S. Sansgiry

   Drug Information 30 December 2013 Pages: 183 - 189

7. Medical Information Specialists: Benchmarks in Practice

   • Kimberly Wu
   • Laura Smith Schmelz
   • Sara M. Doshi

   Drug Information 30 December 2013 Pages: 190 - 197

8. Drug Information Activity and Nonprescription Requests Over the Malaysian Counter

   • Tahir Mehmood Khan
   • Promise Emeka
   • Amer Hayat Khan

   Drug Information 30 December 2013 Pages: 198 - 202

9. Health Care Professionals’ Expectations of the Medical Science Liaison: A Blinded Survey

   • Robert J. Moss
   • Jimmy Black

   Drug Information 30 December 2013 Pages: 203 - 208

10. Medical Information Contact Centers: Challenges and Best Practices

    • David Bowers
    • Timothy Fish

    Drug Information 30 December 2013 Pages: 209 - 213

11. Changes to Prescription Drug Pediatric Labeling: Awareness by Practicing Pediatricians

    • Irwin G. Martin
    • Siva Rama Krishna Thottempudi
    • Daniel A. C. Frattarelli

    Special Populations 30 December 2013 Pages: 214 - 218

12. Drug Information: Prescribers’ Need for and Access to Drug Information Resources in Ethiopia

    • Nezif Hussien
    • Seid Musa
    • Sultan Suleman

    Global Perspectives 30 December 2013 Pages: 219 - 225

13. The Effect of Market-Based Economic Factors on the Adoption of Orphan Drugs Across Multiple Countries

    • John T. Matthews
    • Lucas Glass

    Global Perspectives 30 December 2013 Pages: 226 - 234

14. A Practical Estimation Method for Analyzing Adverse Drug Reactions Using Data Mining

    • Yuko Shirakuni
    • Kousuke Okamoto
    • Tatsuya Takagi

    Statistics 30 December 2013 Pages: 235 - 241

15. Sample Size Calculation for Bioequivalence Studies Assessing Drug Effect and Food Effect at the Same Time With a 3-Treatment Williams Design

    • Jiacheng Yuan
    • Tiejun Tong
    • Man-Lai Tang

    Statistics 30 December 2013 Pages: 242 - 247

16. Safety Information From Spontaneous and Literature Adverse Reaction Reports: A Comparison

    • Janine Klose
    • Simone Fröhling
    • Axel Nolting

    Drug Safety 30 December 2013 Pages: 248 - 255

17. Validation of QT Interval Correction Methods When a Drug Changes Heart Rate

    • Qianyu Dang
    • Joanne Zhang

    Drug Safety 30 December 2013 Pages: 256 - 260

18. Factors Related to Regulatory Approval of Late-Stage Development Compounds: Analysis of Japanese Pharmaceutical Company Activities, 1995–2007

    • Atsushi Tsukamoto
    • Masayuki Kaneko
    • Mamoru Narukawa

    Regulatory Science 30 December 2013 Pages: 261 - 267

19. A Review of Regulatory Mechanisms Used by the WHO, EU, and US to Facilitate Access to Quality Medicinal Products in Developing Countries With Constrained Regulatory Capacities

    • Yauba Saidu
    • Dario De Angelis
    • Anne Marie Georges

    Regulatory Science 30 December 2013 Pages: 268 - 276